Your browser doesn't support javascript.
loading
Prenatal Omega-6:Omega-3 Ratio and Attention Deficit and Hyperactivity Disorder Symptoms.
López-Vicente, Mónica; Ribas Fitó, Núria; Vilor-Tejedor, Natalia; Garcia-Esteban, Raquel; Fernández-Barrés, Sílvia; Dadvand, Payam; Murcia, Mario; Rebagliato, Marisa; Ibarluzea, Jesús; Lertxundi, Aitana; Fernández-Somoano, Ana; Tardón, Adonina; López-Sabater, M Carmen; Romaguera, Dora; Vrijheid, Martine; Sunyer, Jordi; Julvez, Jordi.
Afiliação
  • López-Vicente M; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain; Hospital del Mar Medical Research Institute, Barcelona, Spain. Electronic address: monica.lo
  • Ribas Fitó N; Mental Health Foundation CPB-SSM, Barcelona, Spain.
  • Vilor-Tejedor N; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Garcia-Esteban R; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Fernández-Barrés S; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Dadvand P; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Murcia M; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain; Epidemiology and Environmental Health Joint Research Unit, FISABIO-Jaume I University-University of València, València, Spain.
  • Rebagliato M; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain; Epidemiology and Environmental Health Joint Research Unit, FISABIO-Jaume I University-University of València, València, Spain; Medicine Department, Jaume I University, Castelló de la Plana, Spain.
  • Ibarluzea J; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain; University of Basque Country, San Sebastián, Spain; Health Research Institute, BIODONOSTIA, San Sebastián, Spain; Sub-Directorate of Public Health of Gipuzkoa, Department of Health, Goverment of Basque C
  • Lertxundi A; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain; University of Basque Country, San Sebastián, Spain; Health Research Institute, BIODONOSTIA, San Sebastián, Spain.
  • Fernández-Somoano A; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain; IUOPA-Preventive Medicine and Public Health Area, University of Oviedo, Asturias, Spain.
  • Tardón A; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain; IUOPA-Preventive Medicine and Public Health Area, University of Oviedo, Asturias, Spain.
  • López-Sabater MC; Department of Nutrition, Food Sciences and Gastronomy, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain; Biomedical Research Networking Centres Obesity and Nutrition (CIBEROBN), Madrid, Spain.
  • Romaguera D; Biomedical Research Networking Centres Obesity and Nutrition (CIBEROBN), Madrid, Spain; Balearic Islands Health Research Institute, Son Espases University Hospital, Palma de Mallorca, Spain.
  • Vrijheid M; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Sunyer J; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain; Hospital del Mar Medical Research Institute, Barcelona, Spain.
  • Julvez J; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Biomedical Research Networking Centres Epidemiology and Public Health (CIBERESP), Madrid, Spain; Hospital del Mar Medical Research Institute, Barcelona, Spain.
J Pediatr ; 209: 204-211.e4, 2019 06.
Article em En | MEDLINE | ID: mdl-30929929
ABSTRACT

OBJECTIVE:

To evaluate whether higher omega-6omega-3 (n-6n-3) long-chain polyunsaturated fatty acid ratio in cord plasma is associated with more symptoms of attention deficit and hyperactivity disorder (ADHD) at 4 and 7 years of age. STUDY

DESIGN:

This study was based on a population-based birth cohort in Spain. N-6 arachidonic acid and n-3 eicosapentaenoic and docosahexaenoic acid concentrations were measured in cord plasma. At 4 years old, ADHD symptoms were reported by teachers through the ADHD Diagnostic and Statistical Manual of Mental Disorders, 4th ed checklist (n = 580). At 7 years old, ADHD symptoms were reported by parents through the Conners' Rating Scale-Revised (short form; n = 642). The ADHD variable was treated as continuous (score) and as dichotomous (symptom diagnostic criteria). Child and family general characteristics were prospectively collected through questionnaires. We applied pooled zero-inflated negative binomial and logistic regressions adjusted for covariates.

RESULTS:

A higher omega-6omega-3 long-chain polyunsaturated fatty acid ratio in cord plasma was associated with a higher ADHD index (incidence rate ratio, 1.13; 95% CI, 1.03, 1.23) at 7 years old. The association was not observed at 4 years old (incidence rate ratio, 1.04; 95% CI, 0.92-1.18). No associations were found using ADHD symptom diagnostic criteria.

CONCLUSIONS:

High prenatal omega-6omega-3 long-chain polyunsaturated fatty acid ratio preceded the appearance of subclinical ADHD symptoms during mid-childhood. Our findings suggest that maternal diet during pregnancy may modulate the risk to develop long-term ADHD symptoms in the offspring.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Ácidos Graxos Ômega-3 / Fenômenos Fisiológicos da Nutrição Pré-Natal / Ácidos Graxos Ômega-6 / Sangue Fetal Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Male / Pregnancy Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Ácidos Graxos Ômega-3 / Fenômenos Fisiológicos da Nutrição Pré-Natal / Ácidos Graxos Ômega-6 / Sangue Fetal Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Male / Pregnancy Idioma: En Ano de publicação: 2019 Tipo de documento: Article